Cargando…
iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use?
The use of induced Pluripotent Stem Cells (iPSC) as a source of autologous tissues shows great promise in regenerative medicine. Nevertheless, several major challenges remain to be addressed before iPSC-derived cells can be used in therapy, and experience of their clinical use is extremely limited....
Autores principales: | Attwood, Stephen W., Edel, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462964/ https://www.ncbi.nlm.nih.gov/pubmed/30823421 http://dx.doi.org/10.3390/jcm8030288 |
Ejemplares similares
-
iPS Cells for Modelling and Treatment of Retinal Diseases
por: Chen, Fred K., et al.
Publicado: (2014) -
Beyond iPS!
Publicado: (2012) -
Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014) -
Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy
por: Roca, Isart, et al.
Publicado: (2015) -
iPS cell technologies: significance and applications to CNS regeneration and disease
por: Okano, Hideyuki, et al.
Publicado: (2014)